DEXCOM INC Cash & Equivalents 2008-2026 | DXCM
Beta
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is DEXCOM INC's current cash & equivalents?
DEXCOM INC (DXCM) annual cash & equivalents for 2025 was $917.7M, a 51.41% increase from 2024. DEXCOM INC cash & equivalents for the quarter ending March 31, 2026 was $1.12B.
What was DEXCOM INC's cash & equivalents in 2024?
DEXCOM INC annual cash & equivalents for 2024 was $606.1M, a 7.03% increase from 2023.
What was DEXCOM INC's cash & equivalents in 2023?
DEXCOM INC annual cash & equivalents for 2023 was $566.3M, a 11.97% decline from 2022.
What is DEXCOM INC's 5-year cash & equivalents CAGR?
DEXCOM INC cash & equivalents grew at a compound annual growth rate (CAGR) of 2.32% from FY2020 to FY2025, going from $818.2M to $917.7M over 5 years.
Cash & Equivalents History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+2.3%
FY2020
$818.2M
→
FY2025
$917.7M
080910111213141516171819202122232425
5 years selected
Cash & Equivalents History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $917.7M | +51.4% | 10-K |
| FY2024 | $606.1M | +7.0% | 10-K |
| FY2023 | $566.3M | -12.0% | 10-K |
| FY2022 | $643.3M | -38.9% | 10-K |
| FY2021 | $1.05B | +28.8% | 10-K |
| FY2020 | $818.2M | +83.3% | 10-K |
| FY2019 | $446.4M | -60.7% | 10-K |
| FY2018 | $1.14B | +157.6% | 10-K |
| FY2017 | $441.5M | +367.2% | 10-K |
| FY2016 | $94.5M | +9.8% | 10-K |
| FY2015 | $86.1M | +19.9% | 10-K |
| FY2014 | $71.8M | +66.2% | 10-K |
| FY2013 | $43.2M | +433.3% | 10-K |
| FY2012 | $8.1M | +211.5% | 10-K |
| FY2011 | $2.6M | -46.9% | 10-K |
| FY2010 | $4.9M | +36.1% | 10-K |
| FY2009 | $3.6M | -71.7% | 10-K |
| FY2008 | $12.7M | - | 10-K |
Company: DEXCOM INCTicker: DXCMSector: HealthcareIndustry: Surgical & Medical Instruments & ApparatusView company profile →